aDepartment of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA bDepartment of Urology, University of California Los Angeles, Los Angeles, CA, USA cDivision of General ...

Choosing the right security system for your home is no small decision. You want something reliable, effective, and worth your investment. If you’re based in the Southeast — particularly North Carolina ...

American District Telegraph started back in 1874. Its original line of business involved telegraph delivery and was an affiliation between 57 telegraph delivery companies. Once the telegraph started ...

Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...

Vorwerk, the company that purchased Neato robovacs, is reneging on its promise to keep the bots’ server running for 5 years. Vorwerk, the company that purchased Neato robovacs, is reneging on its ...

Darolutamide, also known as Nubeqa and made by Bayer, is recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen deprivation ...

A nostalgic 1990s video from the Infosys canteen has gone viral, with discussions surrounding the company's early days and its first employees. The user further claimed that, given the massive rise in ...

4,766,220 reviews on ConsumerAffairs are verified. We require contact information to ensure our reviewers are real. We use intelligent software that helps us maintain the integrity of reviews. Our ...

New findings from the EMBARK trial reveal enzalutamide significantly reduces mortality risk in high-risk prostate cancer patients, enhancing treatment options. Patients with nonmetastatic ...

For years, Manchester synagogue attacker Jihad Al-Shamie lay in wait as he viewed terrorist material online, biding his time before he decided to strike. Earlier this month, on Yom Kippur, the holiest ...

Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application with the FDA.

Enzalutamide plus leuprolide significantly improves overall survival and metastasis-free survival in biochemically recurrent prostate cancer compared to leuprolide alone. Subgroup analysis revealed ...